SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies - Quaterly Results

23 Jan 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 4490.50 millions, about 12.65% up against Rs. 3986.40 millions recorded during the year-ago period.Net profit declined -28.20% to Rs. 200.10 millions from Rs. 278.70 millions.OP of the company witnessed a marginal growth to 682.20 millions from 620.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4490.50 3986.40 12.65 13453.20 12392.30 8.56 16666.90 15397.20 8.25
Other Income 29.30 3.70 691.89 44.60 18.40 142.39 23.30 23.20 0.43
PBIDT 682.20 620.20 10.00 2050.80 2225.50 -7.85 2872.20 3293.20 -12.78
Interest 100.30 70.10 43.08 259.10 163.90 58.08 250.30 141.40 77.02
PBDT 499.90 550.10 -9.13 1709.70 2061.60 -17.07 2621.90 3151.80 -16.81
Depreciation 229.70 171.60 33.86 642.50 529.10 21.43 706.00 789.50 -10.58
PBT 270.20 378.50 -28.61 1067.20 1532.50 -30.36 1915.90 2362.30 -18.90
TAX 70.10 99.80 -29.76 276.30 372.70 -25.87 502.30 817.10 -38.53
Deferred Tax 47.70 17.70 169.49 53.30 -55.80 -195.52 -49.70 -73.40 -32.29
PAT 200.10 278.70 -28.20 790.90 1159.80 -31.81 1413.60 1545.20 -8.52
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 15.19 15.56 -2.35 15.24 17.96 -15.12 17.23 21.39 -19.43

Indoco Remedies Share Price

251.25 23.30 (10.22%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×